Wired Herald

2019 Global Plasmid DNA Manufacturing Market to Reach US$ 300 Million By 2026

Press release   •   Feb 11, 2020 01:41 EST

According to Acumen Research, The global ​Plasmid DNA Manufacturing Market is estimated to represent a global market of US$ 300 Mn by 2026 with growth rate of 20% during the forecast era 2019 to 2026. The report provides analysis of global Plasmid DNA Manufacturing Market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.

The report offers a bird’s eye view of the Plasmid DNA Manufacturing Market, gauging its growth trajectory over the years. It presents insights into key factors boosting the markets, besides the ones restricting its growth. The report also highlights hidden opportunities for the market besides revealing the key restraints. It is therefore intended to help market players determine their growth strategies and make informed decisions pertaining to potential investments.

The Plasmid DNA Manufacturing Market study provides a thorough assessment of the present market trends that influences the market growth. The research also involves the industry's market valuation in terms of revenue, forecast data, geographic spectrum, competitive landscape and SWOT analysis. Furthermore, the study describes major challenges and growth opportunities faced by market players in conjunction with their product offerings and business strategies. This study focuses on North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa top competitors.

​Click Here To Get FREE SAMPLE PDF (Including Full TOC, Table & Figures)

Scope of the Report:

The report first uses historic data from different companies. The data collected is used to analyses the growth of industries in the past years. It includes data from the year 2015 to the year 2019. The forecast data provides the reader with an understating of the future of the market. The same data is used to predict the expectation of the companies and how they are expected to evolve in the coming years. The research provides historical as well as estimated data from the year 2019 to 2026. The details in the report give a brief overview of the market by examining its historical data, the current data, and forecast data to understand the growth of the market.

List of Companies

The report lists down some of the leading companies operating in this market. The market share of the global Plasmid DNA Manufacturing Market is dominated by companies like Aldevron, Cobra Biologics Limited, Delphi Genetics, VGXI, Inc., PlasmidFactory GmbH & Co. KG, LakePharma, Inc., Akron Biotech, Waisman Biomanufacturing, Richter-Helm BioLogics, Eurogentec, Kaneka Corporation, Nature Technology Corporation, Cell and Gene Therapy Catapult and among others.

The policies adopted by these companies are studied in detail. Furthermore, the report offers insights into their product portfolio, pricing strategies, strategic collaborations, mergers and acquisitions, among others.

SWOT Analysis is conducted on the companies listed to study their strengths and weaknesses. Furthermore, the analysis offered insights into opportunities and threats present in the market for these companies. A comparative analysis between these companies is intended to highlight the most successful strategies adopted by these companies. Doing so, the report offers recommendations for growth to companies operating in the market. It is thus conducted to help companies, irrespective of their size, access relevant information.

Market Segment Analysis:

Acumen Research report focuses on market attractiveness by assessing the key market segments. The report also combines region-wise segments for a better understanding of the supply and demand ratio of this market. This exclusive study of the report analyzes the present and future market scenario and the industry trends that are influencing the growth of the segments. Besides, the report also covers the value chain analysis, supply chain analysis, and year-on-year basis analysis of this market.

Market Segmentation’s as below:

Market By Application

  • Gene Therapy
  • Vaccinology

Market By Disease

  • Infectious Disease
  • Cancer
  • Genetic Disorder

Market By End use

  • Research Institute
  • Biotech Companies

Market By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of EU
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of LA
  • Middle East & Africa
    • Saudi
    • UAE
    • Rest of MEA

Key Takeaways:

  • What is the market size in 2018 and the growth rate of this research report?
  • What is the market drivers, restrains, opportunities governing the global Plasmid DNA Manufacturing Market?
  • Which is the largest and the fastest growing segments in this report?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

Customize This Report As Per Your Requirement, For Customization >>>​Click Here

TABLE OF CONTENT

Chapter 1. Industry Overview of Plasmid DNA Manufacturing
1.1 Definition and Scope
1.1.1 Definition of Plasmid DNA Manufacturing
1.1.2 Market Segmentation
1.2 Summary
1.2.1 Market Snapshot
1.3 Global Plasmid DNA Manufacturing Market By Application
1.3.1 Global Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.3.2 Gene Therapy
1.3.3 Vaccinology
1.4 Global Plasmid DNA Manufacturing Market By Disease
1.4.1 Global Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By Disease (2015-2026)
1.4.2 Infectious Disease
1.4.3 Genetic Disorders
1.4.4 Cancer
1.5 Global Plasmid DNA Manufacturing Market By End Use
1.5.1 Global Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By End Use (2015-2026)
1.5.2 Research Institutes
1.5.3 Biotech Companies
1.6 Global Plasmid DNA Manufacturing Market by Regions
1.6.1 Global Plasmid DNA Manufacturing Market Size and Growth Rate Comparison by Regions (2015-2026)
1.6.2 North America Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
1.6.3 Europe Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
1.6.4 Asia-Pacific Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
1.6.5 Latin America Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
1.6.6 Middle East & Africa Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)

Chapter 2. Market Dynamics and Competition Analysis
2.1 Market Drivers
2.2 Restraints and Challenges
2.3 Growth Opportunities
2.4 Porter’s Five Forces Analysis
2.4.1 Low Bargaining Power of Suppliers
2.4.2 Medium Bargaining Power of Buyers
2.4.3 High Threat of Substitute
2.4.4 Low Threat of New Entrants
2.4.5 High Degree of Competition
2.5 Value Chain Analysis
2.6 Cost structure Analysis
2.6.1 Raw Material and Suppliers
2.6.2 Proportion of Manufacturing Cost Structure
2.6.2.1 Raw Material
2.6.2.2 Labor Cost
2.6.2.3 Manufacturing Expense
2.7 Regulatory Compliance
2.8 Competitive Landscape, 2018
2.8.1 Player Positioning Analysis
2.8.2 Key Strategies Adopted By Leading Players

Chapter 3. Manufacturing Plant Analysis
3.1 Revenue and Commercial Date of Global Plasmid DNA Manufacturing Major Manufacturers in 2018
3.2 Manufacturing Plants Distribution of Global Plasmid DNA Manufacturing Major Manufacturers in 2018

Chapter 4. Plasmid DNA Manufacturing Market By Application
4.1 Global Plasmid DNA Manufacturing Revenue by Application
4.2 Gene Therapy
4.2.1 Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
4.2.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$ Million)
4.3 Vaccinology
4.3.1 Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
4.3.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$ Million)

Chapter 5. Plasmid DNA Manufacturing Market By Disease
5.1 Global Plasmid DNA Manufacturing Revenue by Disease
5.2 Infectious Disease
5.2.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
5.2.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)
5.3 Genetic Disorders
5.3.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
5.3.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)
5.4 Cancer
5.4.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
5.4.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)

Chapter 6. Plasmid DNA Manufacturing Market By End Use
6.1 Global Plasmid DNA Manufacturing Revenue by End Use
6.2 Research Institutes
6.2.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
6.2.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)
6.3 Biotech Companies
6.3.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
6.3.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)

Chapter 7. North America Plasmid DNA Manufacturing Market By Country
7.1 North America Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
7.2 North America Plasmid DNA Manufacturing Market Revenue Share, by Country, 2018 (%)
7.3 U.S.
7.3.1 U.S. Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
7.3.2 U.S. Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
7.3.3 U.S. Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
7.4 Canada
7.4.1 Canada Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
7.4.2 Canada Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
7.4.3 Canada Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 8. Europe Plasmid DNA Manufacturing Market By Country (8)
8.1 Europe Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
8.2 Europe Plasmid DNA Manufacturing Market Revenue Share, By Country, 2018 (%)
8.3 UK
8.3.1 UK Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
8.3.2 UK Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
8.3.3 UK Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.4 Germany
8.4.1 Germany Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
8.4.2 Germany Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
8.4.3 Germany Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.5 France
8.5.1 France Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
8.5.2 France Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
8.5.3 France Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.6 Spain
8.6.1 Spain Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
8.6.2 Spain Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
8.6.3 Spain Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.7 Italy
8.7.1 Italy Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
8.7.2 Italy Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
8.7.3 Italy Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.8 Rest of Europe
8.8.1 Rest of Europe Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
8.8.2 Rest of Europe Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
8.8.3 Rest of Europe Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 9. Asia-Pacific Plasmid DNA Manufacturing Market By Country
9.1 Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
9.2 Asia-Pacific Plasmid DNA Manufacturing Market Revenue Share Comparison, By Country, 2015 & 2026 (%)
9.3 China
9.3.1 China Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
9.3.2 China Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
9.3.3 China Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.4 Japan
9.4.1 Japan Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
9.4.2 Japan Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
9.4.3 Japan Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.5 India
9.5.1 India Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
9.5.2 India Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
9.5.3 India Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.6 Australia
9.6.1 Australia Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
9.6.2 Australia Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
9.6.3 Australia Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.7 South Korea
9.7.1 South Korea Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
9.7.2 South Korea Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
9.7.3 South Korea Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.8 Rest of Asia-Pacific
9.8.1 Rest of Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
9.8.2 Rest of Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
9.8.3 Rest of Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 10. Latin America Plasmid DNA Manufacturing Market By Country
10.1 Latin America Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
10.2 Latin America Plasmid DNA Manufacturing Market Revenue Share, by Country, 2018 (%)
10.3 Brazil
10.3.1 Brazil Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
10.3.2 Brazil Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
10.3.3 Brazil Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
10.4 Mexico
10.4.1 Mexico Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
10.4.2 Mexico Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
10.4.3 Mexico Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
10.5 Rest of Latin America
10.5.1 Rest of Latin America Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
10.5.2 Rest of Latin America Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
10.5.3 Rest of Latin America Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 11. Middle East & Africa Plasmid DNA Manufacturing Market By Country
11.1 Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
11.2 Middle East & Africa Plasmid DNA Manufacturing Market Revenue Share Comparison, By Countries, 2018 (%)
11.3 Saudi Arabia
11.3.1 Saudi Arabia Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
11.3.2 Saudi Arabia Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
11.3.3 Saudi Arabia Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
11.4 UAE
11.4.1 UAE Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
11.4.2 UAE Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
11.4.3 UAE Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
11.5 Rest of Middle East & Africa
11.5.1 Rest of Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
11.5.2 Rest of Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
11.5.3 Rest of Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 12. Major Manufacturers Analysis of Plasmid DNA
12.1 Cobra Biologics Limited
12.1.1 Business Overview
12.1.2 Company Profile
12.1.3 Cobra Biologics Limited 2018 Financial Analysis
12.1.4 Cobra Biologics Limited 2018 Plasmid DNA Business Region Distribution Analysis
12.1.5 Product Segment
12.1.6 Marketing Strategy and Recent Development
12.2 Novasep Inc.
12.2.1 Business Overview
12.2.2 Company Profile
12.2.3 Novasep Inc. 2018 Financial Analysis
12.2.4 Novasep Inc. 2018 Plasmid DNA Business Region Distribution Analysis
12.2.5 Product Segment
12.2.6 Marketing Strategy and Recent Development
12.3 Spark Therapeutics, Inc.
12.3.1 Business Overview
12.3.2 Company Profile
12.3.3 Spark Therapeutics, Inc. 2018 Financial Analysis
12.3.4 Spark Therapeutics, Inc. 2018 Plasmid DNA Business Region Distribution Analysis
12.3.5 Product Segment
12.3.6 Marketing Strategy and Recent Development
12.4 FUJIFILM Diosynth Biotechnologies Inc.
12.4.1 Business Overview
12.4.2 Company Profile
12.4.3 FUJIFILM Diosynth Biotechnologies Inc. 2018 Financial Analysis
12.4.4 FUJIFILM Diosynth Biotechnologies Inc. 2018 Plasmid DNA Business Region Distribution Analysis
12.4.5 Product Segment
12.4.6 Marketing Strategy and Recent Development
12.5 Cell and Gene Therapy Catapult
12.5.1 Business Overview
12.5.2 Company Profile
12.5.3 Cell and Gene Therapy Catapult 2018 Plasmid DNA Sales, Ex-factory Price, Revenue, Gross Margin Analysis
12.5.4 Cell and Gene Therapy Catapult 2018 Plasmid DNA Business Region Distribution Analysis
12.5.5 Product Segment
12.5.6 Marketing Strategy and Recent Development
12.6 Kaneka Eurogentec S.A (KANEKA)
12.6.1 Business Overview
12.6.2 Company Profile
12.6.3 Kaneka Eurogentec S.A 2018 Plasmid DNA Sales, Ex-factory Price, Revenue, Gross Margin Analysis
12.6.4 Kaneka Eurogentec S.A 2018 Plasmid DNA Business Region Distribution Analysis
12.6.5 Product Segment
12.6.6 Marketing Strategy and Recent Development
12.7 UniQure N.V.
12.7.1 Business Overview
12.7.2 Company Profile
12.7.3 uniQure N.V. Financial Analysis, 2019
12.7.4 uniQure N.V Plasmid DNA Business Region Distribution Analysis, 2019
12.7.5 Product Segment
12.7.6 Marketing Strategy and Recent Development
12.8 Lonza
12.8.1 Business Overview
12.8.2 Company Profile
12.8.3 Lonza Financial Analysis, 2018
12.8.4 Lonza Plasmid DNA Business Region Distribution Analysis, 2018
12.8.5 Product Segment
12.8.6 Marketing Strategy and Recent Development
12.9 Merk KgaA
12.9.1 Business Overview
12.9.2 Company Profile
12.9.3 Merk KgaA Financial Analysis, 2018
12.9.4 Merk KgaA Plasmid DNA Business Region Distribution Analysis, 2018
12.9.5 Product Segment
12.9.6 Marketing Strategy and Recent Development

Chapter 13. Research Approach
13.1 Methodology
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources

Buy this Premium Research Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1583

Contact Us:

Email: sales@acumenresearchandconsulting.com

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com

Follow Us: LinkedIN | Twitter

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.